Strictly, loss of Sirt4 protected the mice from Ang II-induced cardiac hypertrophy, whereas cardiac overexpression of Sirt4 accelerated cardiac maladaptation in response to Ang II treatment. Here, SIRT4 is linked to cardiac hypertrophy.